Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × bermekimab × Clear all

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Cyclophosphamide 346 Carboplatin 292 pembrolizumab 274 Gemcitabine 274 Cisplatin 273 Radiotherapy 259 Paclitaxel 254 Docetaxel 250 Bevacizumab 214 Rituximab 203 Capecitabine 193 Nivolumab 184 Dexamethasone 175 Fluorouracil 171 fludarabine 159 Oxaliplatin 151 Doxorubicin 137 Leucovorin 127 Irinotecan 127 Pemetrexed 125 Etoposide 125 Cytarabine 122 fludarabine phosphate 113 Bortezomib 112 Lenalidomide 108 Filgrastim 108 Cetuximab 104 Erlotinib Hydrochloride 103 Temozolomide 96 Trastuzumab 93

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01767857 2021-06-29

XCITE

Janssen Research & Development, LLC

Phase 3 Terminated

643 enrolled 16 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡